Sumitomo Mitsui Trust Group Inc. Purchases 4,615 Shares of Cardinal Health, Inc. $CAH

Sumitomo Mitsui Trust Group Inc. raised its position in Cardinal Health, Inc. (NYSE:CAH) by 0.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 629,697 shares of the company’s stock after buying an additional 4,615 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned 0.27% of Cardinal Health worth $98,837,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Integrated Wealth Concepts LLC grew its stake in shares of Cardinal Health by 6.9% in the first quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock valued at $601,000 after acquiring an additional 280 shares in the last quarter. Jones Financial Companies Lllp grew its position in shares of Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after purchasing an additional 14,034 shares in the last quarter. Strs Ohio acquired a new position in shares of Cardinal Health during the 1st quarter worth approximately $2,652,000. Thurston Springer Miller Herd & Titak Inc. increased its holdings in shares of Cardinal Health by 7.9% during the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,074 shares of the company’s stock worth $181,000 after purchasing an additional 79 shares during the period. Finally, Parallel Advisors LLC raised its position in shares of Cardinal Health by 8.8% in the second quarter. Parallel Advisors LLC now owns 2,732 shares of the company’s stock valued at $459,000 after buying an additional 221 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on CAH shares. TD Cowen increased their price target on Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, November 3rd. Citigroup upgraded Cardinal Health from a “neutral” rating to a “buy” rating and upped their target price for the company from $190.00 to $244.00 in a research report on Friday. Deutsche Bank Aktiengesellschaft increased their target price on Cardinal Health from $195.00 to $208.00 and gave the stock a “hold” rating in a report on Tuesday, November 18th. Argus raised their price target on Cardinal Health from $189.00 to $211.00 and gave the stock a “buy” rating in a research report on Tuesday, November 4th. Finally, Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 8th. Fourteen equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $214.07.

Cardinal Health Stock Performance

Shares of CAH opened at $208.08 on Wednesday. Cardinal Health, Inc. has a 52-week low of $119.92 and a 52-week high of $214.93. The firm has a market cap of $49.44 billion, a price-to-earnings ratio of 31.38, a PEG ratio of 1.47 and a beta of 0.65. The business’s fifty day moving average is $204.54 and its 200-day moving average is $173.77.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating the consensus estimate of $2.22 by $0.33. Cardinal Health had a negative return on equity of 84.37% and a net margin of 0.68%.The business had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. During the same period last year, the firm posted $1.88 earnings per share. Cardinal Health’s revenue was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be paid a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is presently 30.77%.

Key Cardinal Health News

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Cardinal raised FY‑2026 EPS guidance to at least $10, cited accelerating specialty revenue (>$50B target) and announced strategic wins (IRA transition, new ContinuCare™ Pathway and a Publix partnership) — the core catalyst cited by management at J.P. Morgan. PR Newswire: Cardinal Health Raises Fiscal 2026 Outlook
• Positive Sentiment: Major business-media pieces note the guidance raise and specialty growth narrative as the reason for the stock jump and upgraded investor sentiment. Benzinga: Cardinal Health Lifts 2026 Profit Outlook
• Positive Sentiment: Barron’s explained why the guidance lift and specialty revenue trajectory make 2026 a constructive year for the stock, reinforcing buy‑side interest. Barron’s: Cardinal Health Stock Jumps on Guidance Raise
• Neutral Sentiment: The company’s full J.P. Morgan presentation/transcript provides detail on strategy execution and was used to support the guidance update; useful for modeling but not new on the headline guidance. Seeking Alpha: J.P. Morgan Presentation Transcript
• Neutral Sentiment: Analyst coverage and fair‑value views are shifting upward as sell‑side models incorporate the stronger FY26 guide and specialty momentum. Yahoo Finance: Analyst Upgrades & Specialty Focus
• Negative Sentiment: Short interest rose materially in December (≈23.6% increase to ~6.06M shares), which can add downside risk or volatility if sentiment reverses. (No article link provided)
• Negative Sentiment: Some commentary questions valuation after a multi‑year run and steep share gains — investors should weigh the beat/guidance versus premium multiples. Yahoo Finance: Has Cardinal Health Run Too Far?

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.